News

Cannabis-extract drinks set for US

Most popular

The just-drinks analyst returns

Heineken must cut costs to aid recovery - analysis

The just-drinks analyst returns

Interview - Treasury CEO Mike Clarke - Part II

How COVID has accelerated the sobriety trend

MORE

US companies Noho and Miracle Smoke have partnered to develop, manufacture and distribute cannabidiol beverages throughout the US.

Cannabidiol is a non-psychoactive component found in cannabis and it is said to have medicinal benefits.

The closing of the proposed transaction is subject to the completion of due diligence and other agreements and it is scheduled on or before 30 June.

Jay Grdina, CEO of Noho said: "We have been researching the cannabidiol (CBD) landscape over the last year and believe it to really be a strong market for us to enter into.

"We believe together with Miracle Smoke we can develop a superior product to what is currently in the fragmented market space. Once we finalise the development of our first CBD pain-relieving beverage products we will be adding them into our current Noho retail distribution network."

Noho produces 2oz shot The Hangover Defense.

Tom Flair from CBD industry watchdog CBDRA.org said: "All the Miracle products that we have ever tested have been the highest quality and most potent available. This is a great time to combine CBD products with a company like Noho."

Earlier this month, just-drinks news and insight editor Andy Morton spotted closer ties between the cannabis and alcohol industries in the US.


Sectors: Cannabis, Soft drinks

Related Content

Where to position cannabis-infused soft drinks for the greatest success - Comment

Where to position cannabis-infused soft drinks for the greatest success - Comment...

US government body issues warning over CBD use

US government body issues warning over CBD use...

Why Canada will shape the rules for cannabis beverages - Comment

Why Canada will shape the rules for cannabis beverages - Comment...

COVID-19 a double-edged sword for CBD product launches - analysis - FREE TO READ

COVID-19 a double-edged sword for CBD product launches - analysis - FREE TO READ...

Oops! This article is copy protected.

Why can’t I copy the text on this page?

The ability to copy articles is specially reserved for people who are part of a group membership.

How do I become a group member?

To find out how you and your team can copy and share articles and save money as part of a group membership call Sean Clinton on
+44 (0)1527 573 736 or complete this form..



Forgot your password?